StocksMedium•5 November 2026•
1 min read
Rigel Pharmaceuticals Beats Q3 2026 Revenue Estimates
Key Facts
1Rigel Pharmaceuticals reported Q3 2026 revenue of $80.9 million.
2The company's revenue exceeded the FactSet consensus estimate of $80.1 million.
Rigel Pharmaceuticals reported Q3 2026 revenue of $80.9 million. Benzinga reported that the company's revenue exceeded the FactSet consensus estimate of $80.1 million.
RIGL closed at $51.29 on November 4, 2026. The stock traded between a day low of $49.23 and a day high of $51.74 during that session.